MacLaren is also hopeful of
stopping choroideremia before significant loss of vision.
However, MacLaren is hopeful that the therapy could also be used to
stop choroideremia before there is any significant loss of vision.
Not exact matches
A fault in the CHM gene causes
choroideremia, in which cells in the retina
stop working and slowly die, leading to blindness.